Beta2-microglobulin in the assessment of renal function in full term newborns following perinatal...

7
Fernandez et al, ß 2 microglobulin and renal function after perinatal asphyxia 453 J. Perinat. Med. 17 (1989) 453 Beta-2-microglobulin in the assessment of renal function in full term newborns following perinatal asphyxia Fernando Fernandez 2 , Vicente Barrio 1 , Juana Guzman 2 , Maria Dolores Huertas 2 , Mercedes Zapatero 2 , Maria Dolores de Miguel 2 , and Jesus Mallol 3 Service of Nephrology, 2 Unit of Neonatology, Department of Pediatrics, and 3 Service of Nuclear Medicine, "Reina Sofia" Hospital, Cordoba, Spain 1 Introduction Perinatal asphyxia has been recognized as a cause of acute renal failure (ARF) in the new- born [1, 8, 19]. The initial response to intrauter- ine hypoxia is a redistribution of cardiac output with a decrease in renal perfusion among other organs, in order to preserve perfusion to vital organs including brain, heart, and adrenal glands [4, 6]. Renal proximal tubule is particularly sus- ceptible to hypoxia [20], as reflected by a marked decrease in reabsorption capacity following this insult. Beta-2 microglobulin 2 -m) is a low mo- lecular weight protein freely filtered through the glomerular capillary wall and almost completely reabsorbed by proximal tubular cells. Therefore, urinary excretion of ß 2 -m is very small [18, 21]. Tubular damage secondary to hypoxia [7, 22], ischemia [13], and nephrotoxic agents [2, 11] results in increased urinary levels of ß 2 -m. The aim of the present study was to evaluate the clinical usefulness of ß 2 -m determination in serum and urine in the diagnosis of renal dys- function in full term neonates following as- phyxia, and to compare these tests with tradi- tional indices of renal function such as plasma creatinine (Cr), endogenous creatinine clearance (Ccr), and fractional sodium excretion. 2 Methods From December 1986 through March 1988, forty full term newborns were studied. The group of asphyxiated infants comprised twenty newborns with a mean birth weight of 3180 ± 325 g, all Curriculum vitae FERNANDO FERNANDEZ, M.D., was graduated from Cantabria Univer- sity in 1979and qualified as a specialist in Pediat- rics at Children's Hospi- tal "La Paz" Madrid, Spain in 1984. He had a fellowship in Neonatol- ogy at the same Hospital in 1984. Since 1986 he has been on the staff of Department of Pediatrics, Children's Hospital "Reina Sofia", Cordoba, Spain. His main research interest is in the field of perinatal asphyxia. of which met at least three of the following criteria: 1. Abnormal fetal heart rate monitoring 2. Apgar score under 4 at one minute, and under 6 at five minutes of life 3. Requirement for more than one minute of positive pressure ventilation before spontaneous sustained respiration occurred 4. Metabolic acidosis with pH < 7.2 within twenty minutes of birth. The control group included twenty full term in- fants with a mean birth weight of 3271 + 295 g who were delivered normally after an uncompli- cated pregnancy. None of them presented clinical nor biochemical signs of asphyxia. 1989 by Walter de Gruyter & Co. Berlin · New York

Transcript of Beta2-microglobulin in the assessment of renal function in full term newborns following perinatal...

Fernandez et al, ß2 microglobulin and renal function after perinatal asphyxia 453

J. Perinat. Med.17 (1989) 453

Beta-2-microglobulin in the assessment of renal function in full termnewborns following perinatal asphyxia

Fernando Fernandez2, Vicente Barrio1, Juana Guzman2, Maria Dolores Huertas2,Mercedes Zapatero2, Maria Dolores de Miguel2, and Jesus Mallol3

Service of Nephrology, 2Unit of Neonatology, Department of Pediatrics, and3Service of Nuclear Medicine, "Reina Sofia" Hospital, Cordoba, Spain

1 Introduction

Perinatal asphyxia has been recognized as acause of acute renal failure (ARF) in the new-born [1, 8, 19]. The initial response to intrauter-ine hypoxia is a redistribution of cardiac outputwith a decrease in renal perfusion among otherorgans, in order to preserve perfusion to vitalorgans including brain, heart, and adrenal glands[4, 6]. Renal proximal tubule is particularly sus-ceptible to hypoxia [20], as reflected by a markeddecrease in reabsorption capacity following thisinsult. Beta-2 microglobulin (ß2-m) is a low mo-lecular weight protein freely filtered through theglomerular capillary wall and almost completelyreabsorbed by proximal tubular cells. Therefore,urinary excretion of ß2-m is very small [18, 21].Tubular damage secondary to hypoxia [7, 22],ischemia [13], and nephrotoxic agents [2, 11]results in increased urinary levels of ß2-m.The aim of the present study was to evaluate theclinical usefulness of ß2-m determination inserum and urine in the diagnosis of renal dys-function in full term neonates following as-phyxia, and to compare these tests with tradi-tional indices of renal function such as plasmacreatinine (Cr), endogenous creatinine clearance(Ccr), and fractional sodium excretion.

2 Methods

From December 1986 through March 1988, fortyfull term newborns were studied. The group ofasphyxiated infants comprised twenty newbornswith a mean birth weight of 3180 ± 325 g, all

Curriculum vitae

FERNANDO FERNANDEZ,M.D., was graduatedfrom Cantabria Univer-sity in 1979 and qualifiedas a specialist in Pediat-rics at Children's Hospi-tal "La Paz" Madrid,Spain in 1984. He had afellowship in Neonatol-ogy at the same Hospitalin 1984. Since 1986 hehas been on the staff ofDepartment of Pediatrics, Children's Hospital "ReinaSofia", Cordoba, Spain. His main research interest isin the field of perinatal asphyxia.

of which met at least three of the followingcriteria:1. Abnormal fetal heart rate monitoring2. Apgar score under 4 at one minute, and under6 at five minutes of life3. Requirement for more than one minute ofpositive pressure ventilation before spontaneoussustained respiration occurred4. Metabolic acidosis with pH < 7.2 withintwenty minutes of birth.

The control group included twenty full term in-fants with a mean birth weight of 3271 + 295 gwho were delivered normally after an uncompli-cated pregnancy. None of them presented clinicalnor biochemical signs of asphyxia.

1989 by Walter de Gruyter & Co. Berlin · New York

454 Fernandez et al, ß2 microglobulin and renal function after perinatal asphyxia

None of the infants showed major congenitalabnormalities, respiratory distress syndrome,cardiac dysfunction, hyperbilirubinemia, renaldisease nor received nephrotoxic drugs. All as-phyxiated infants were given 60 ml/kg of iv fluid(10% dextrose in water) on the first day of life.Fluid and electrolyte intake was subsequentlyadjusted according to patient's clinical status.Infants in the control group received formuladuring the first four to six hours after birth andwere thereafter fed ad libitum every three hours.Renal function was evaluated in both groups onthe first and third day of life by means of serumand urinary levels of creatinine, sodium, and ß2-m. Timed 8 hours urine samples were collectedusing a urine bag placed over the infant's exter-nal genitalia. Manual suprapubic pressure wasapplied at the end of the collection interval toensure completeness. When urinary pH was lessthan 6.0, alkalinazation was obtained with so-dium hydroxide to prevent ß2-m inactivation. Atthe midpoint of urine collection, 3 ml of bloodwere drawn from an umbilical catheter or pe-ripheral vein and immediately centrifuged.Serum and urine samples were stored at — 20 °Cuntil analyzed. ß2-m was measured by radioim-munosorbent assay (Phadebas, ß2 microtest,Pharmacia Diagnostics, Uppsala, Sweden).Creatinine clearance, fractional excretion of so-dium (FeNa), and fractional excretion of ß2-m(Feß2-m) were calculated as follows:

Ccr (ml/min 1.73 m2) = (V Ucr/Pcr) (1.73/BSA)CNa (ml/min 1.73 m2) = (V UNa/PNa)(1.73/BSA)FeNa (%) = CNa/CcrCß2-m (ml/min 1.73 m2) = (V Uß2-m/Pß2-m)(1.73/BSA)Feß2-m (%) = Cß2-m/Ccr

where BSA = Body Surface Area, C = Clear-ance, Na = Sodium (mEq/1), Cr = creatinine(mg/dl), V = Urine flow (ml/min), P = Plasma,U = Urine.All results are given as the mean ± one standarddeviation. Statistical analysis was performedwith Statistical Analysis System (SAS) software[17], and included Student's t test for unpaireddata, and repeated measures analysis of variance.Multiple comparisons were adjusted accordingto Scheffe's multiple F tests on all main-effectmeans. Correlation coefficients were determined;P values < 0.05 were considered significant. Sen-

sitivity, and specificity of urinary ß2-m/Cr ratio,Feß2-m, and FeNa as indices of proximal tubularinjury following asphyxia were evaluated.

3 ResultsIn the group of asphyxiated infants, 11 out of20 presented oliguria defined by a urinary flowrate of less than 0.8 ml/kg per hour and 5 oliguricacute renal failure defined by a urinary flow rateof less than 1.0 ml/kg per hour which failed torespond to volume repletion along with serumcreatinine greater than 1.5 mg/dl. Ten as-phyxiated infants with oliguria presented Apgarscores under 4 at 5 minutes of life and pH< 7.10.A summary of global results on the first andthird day of life for both groups of patients isdisplayed on table I. Significant differences be-tween controls and asphyxiated full term infantswere found, on both day 1 and 3, for serumcreatinine (p < 0.01), endogenous creatinineclearance (p < 0.01), urinary ß2-m/creatinine ra-tio (p < 0.01), fractional Na excretion(p < 0.01), and fractional excretion of ß2-m(p < 0.01). On the other hand, no differenceswere observed in serum ß2-m.In asphyxiated neonates stratified by the pres-ence or absence of oliguria or acute renal failureas defined above (table II), infants with oliguriapresented significantly higher values of serumcreatinine (p < 0.05) and Feß2-m (p < 0.05) onthe first day of life. Urinary ß2-m/creatinine ratiowas only significantly increased in infants witholiguria. On day 3, serum creatinine levels wereonly significantly elevated in asphyxiated infantswith acute renal failure. No significant differ-ences in creatinine clearance, FeNa, urinary ß2-m/creatinine, nor in Feß2-m were observed.In asphyxiated infants on the first day of life,urinary ß2-m/creatinine ratio was significantlycorrelated with serum ß2-m (r = 0.48, p < 0.05),FeNa (r = 0.59, p < 0.01), and with Feß2-m(r = 0.70, p < 0.01), but not with serum creati-nine. Feß2-m was significantly correlated withFeNa (r = 0.66, p < 0.66, p < 0.01), but neitherwith serum ß2-m, serum creatinine, nor with cre-atinine clearance. FeNa was not correlated withserum creatinine and neither with creatinineclearance. On day 3, urinary ß2-m/creatinine ra-tio correlated with FeNa (r = 0.52, p < 0.05),and with Feß2-m (r = 0.53, p < 0.05). Addition-

J. Perinat Med. 17 (1989)

Fernandez et al, ß2 microglobulin and renal function after perinatal asphyxia 455

Table I. Summary of traditional renal function tests and determinations of ß2-m in serum and urine

Controls:First dayThird dayAsphyctic:First dayThird day

Serum Cr

(mg/dl)

0.8 + 0.10.6 ± 0.1

1.1 ± 0.2*0.9 + 0.3*

Cr Clearance(ml/min1.73 m2)

31.7 ± 5.235.2 + 7.9

21.3 + 4.9*27.4 + 7.8*

FeNa

0.40.3

1.21.0

±±

0.20.1

0.5*0.5*

Serum

( §/

3.4 ±3.4 ±

4.1 +3.7 ±

ß2-m

)

0.50.5

1.61.4

Urinaryß2-m/Cr(>g/mg)

22.4 ±21.1 ±

62.2 +52.5 +

11.79.6

31.6*18.0*

Feß2-m

4.9 +3.8 ±

16.5 ±13.8 ±

3.01.9

11.5*9.4*

Between groups comparisons on the same day *p < 0.01.

Table . Summary of tests stratified by the presence of oliguria and of acute renal failure

Oliguria: (11)First dayThird dayNormal diuresis:First dayThird dayARF:(5)First dayThird dayNormal function:First dayThird day

Serum Cr

(mg/dl)

1.3 ± 0.30.9 ± 0.4

1.0 ± 0.1*0.9 ± 0.3

1.5 + 0.11.6 ± 0.4

1.0 ± 0.9*0.9 ± 0.3*

Cr Clearance(ml/min1.73 m2)

20.2 + 5.624.0 ± 7.7

22.1 + 4.024.8 ± 7.7

16.8 + 2.722.0 ± 6.2

22.8 + 4.3*25.2 ± 7.9

FeNa

(%)

1.5 + 0.71.0 ± 0.6

1.1 ± 0.40.9 ± 0.4

1.6 ± 0.61.0 ± 0.4

1.2 ± 0.61.0 ± 0.5

Urinaryß2-m/Cr^g/mg)

78.3 + 42.257.0 ± 30.4

49.0 ± 26.3*48.8 ± 26.9

65.2 ± 35.050.6 ± 20.8

61.2 + 44.753.1 ± 30.7

Feß2-m

(%)

22.7 ± 13.516.0 ± 11.3

11.6 ± 5.7*12.5 ± 7.1

26.4 +11.414.6 ± 4.3

13.3 + 7.5*13.6 + 10.5

Numbers in parentheses represent n. Within groups comparisons on the same day *p < 0.05.

ally, Feß2-m was significantly correlated withFeNa (r = 0.78, p < 0.01).Values situated two standard deviations abovethe mean of the control group were consideredas the upper limit of normal. According to this,on the first day of life 14 out of 20 asphyxiatedneonates in contrast to only 1 neonate in thecontrol group had elevated urinary ß2-m/creati-nine ratio. Similarly, 15 out of 20 asphyxiatedneonates and 1 in the control group had elevatedlevels of Feß2-m. Finally, 13 out of 20 as-phyxiated neonates and 3 out of 20 in the control

J. Perinat. Med. 17 (1989)

group presented elevated levels of FeNa. Sensi-tivity of urinary ß2-m/creatinine ratio, Feß2-m,and FeNa were 0.70, 0.75, and 0.65, and speci-ficity 0.95, 0.95, and 0.85 respectively.

4 Discussion

Results of the present study demonstrate thatperinatal hypoxia causes impairment of tubularfunction as evidenced by an increase in urinaryß2-m/creatinine ratio, fractional excretion of ß2-m, and fractional excretion of Na. The degree

456 Fernandez et al, ß2 microglobulin and renal function after perinatal asphyxia

of tubular dysfunction seems to be related to theseverity of the ischemic insult since those neo-nates with more severe asphyxia, reflected bylower blood pH and Apgar scores, developedoliguria and/or acute renal failure, and had thehighest levels of urinary ß2-m/creatinine ratioand Feß2-m on the first day of life.Values of serum ß2-m of the present study in thecontrol group are consistent with previous re-ports [10, 3, 23]. There were no differences inserum ß2-m levels between the control group andthose of asphyxiated infants. Additionally, serumß2-m was neither correlated with serum creati-nine nor with creatinine clearance. This precludesthe use of serum ß2-m as an index of glomerularfiltration rate in neonates, in contrast to adultswhere several studies have pointed out to itsusefulness [5,14].Since it has been suggested that urinary ß2-mmay be dependent on urine flow rate [10], al-though the point is controversial, urinary ß2-mwas factored by urinary creatinine. Values ofurinary ß2-m/creatinine ratio and Feß2-m in thecontrol group are similar to those reported inthe literature [10, 3]. Urinary ß2-m/creatinine ra-tio and Feß2-m in the present study have shownsignificant increases both on the first and thirdday after asphyxia with respect to the controlgroup.When comparison was restricted to the neonatesstratified by the presence or absence of oliguriaor acute renal failure, only urinary ß2-m/creati-nine ratio and Feß2-m during the first day weresignificantly increased. Two previous reports in-dicate increased levels of urinary ß2-m secondaryto proximal tubular dysfunction following peri-natal hypoxia. COLE et al. [7], in a study including65 full term newborns, found that infants withmeconium stained amniotic fluid, mainly thosewith low Apgar score, presented elevated urinaryß2-m levels. Recently, TACK et al. [22] described

elevated urinary ß2-m levels in preterm and termasphyctic newborns. Urinary ß2-m/creatinine ra-tios in the present study display lower values,probably due to the inclusion in their study ofpreterm newborns, many of them less than 35weeks which is the time when glomerular tubularbalance is established [3]. Since serum ß2-m andurinary ß2-m/creatinine ratio were not correlatedand did not differ significantly between controland asphyctic groups, we may suggest that serumß2-m levels did not contribute to urinary ß2-mlevels. Likewise, since no tubular maximum (Tm)for human ß2-m reabsorption has been found[12], the filtered load of ß2-m has little, if any,effect on urinary ß2-m levels.

FeNa has commonly been used to estimate renaltubular function in neonates [15, 16, 9]. Usually,a FeNa greater than 2.5 to 3% is present in mostneonates with oliguric acute renal failure [16].ELLIS and ARNOLD [9] found that a FeNa above2.5% was present in all neonates with oliguricacute renal failure, but unfortunately similar fig-ures were found in infants with prerenal oliguria.In the present study, although we observed ele-vated FeNa values in the group of asphyxiatedneonates, FeNa was not able to discriminatebetween the presence or absence of oliguria oracute renal failure. On the first day of life, only1 out of 5 of those infants who developed acuterenal failure presented FeNa levels above 2.5%.Therefore, FeNa seems to be less sensitive andspecific than urinary ß2-m/creatinine ratio orFeß2-m to identify tubular proximal dysfunctionfollowing perinatal asphyxia.

In summary, in the present study, urinary ß2-m/creatinine ratio and fractional excretion of ß2-mappear to be sensitive and specific tests for theearly detection of renal proximal tubular dys-function following perinatal asphyxia, providingbetter information than that obtained throughtraditional tests of renal function.

Abstract

In order to evaluate the clinical usefulness of serumand urinary ß2 microglobulin (ß2-m) determination asa marker of renal damage following perinatal asphyxia,twenty asphyxiated and twenty healthy full term new-borns were studied. Renal function was monitored onthe first and third day after birth by traditional testssuch as creatinine (Cr), endogenous creatinine clear-ance (Ccr), and fractional Na excretion (FeNa), as

well as by serum and urinary ß2 microglobulin. Thevalue of different tests for the diagnosis of oliguriaand of acute renal failure was determined. Elevenasphyxiated neonates developed oliguria and five ARFin contrast to none of the controls. Both traditionaltests of renal function, and determinations of ß2-mwith the exception of serum ß2-m, were significantlydifferent (p < 0.01) between controls and asphyxiated

J. Perinat. Med. 17 (1989)

Fernandez et al, ß2 microglobulin and renal function after perinatal asphyxia 457

neonates. When stratified analysis was performed, onlyserum cr, urinary ß2-m/cr ratio, and Feß2-m were ableto discriminate oliguria from preserved diuresis on thefirst day of life. For ARF, only Ccr and Feß2-m weredifferent, again on the first day of life. Urinary ß2-m/

creatinine ratio and Feß2-m appear to be more sensitiveand specific for the early detection of proximal tubularrenal dysfunction following perinatal asphyxia thanusual tests of renal function.

Keywords: ß2 microglobulin, perinatal asphyxia, renal function tests, sensitivity, specificity.

Zusammenfassung

p2-Mikroglobulin als Parameter der Nierenfunktion beiReifgeborenen nach perinataler AsphyxieUm die Brauchbarkeit einer ß2-Mikroglobulin-Bestim-mung (ß2-m) im Serum und Urin als Marker einerrenalen Schädigung nach perinataler Asphyxie zu über-prüfen, untersuchten wir 20 reife, asphyktische Neu-geborene, auf die mindestens 3 der folgenden Kriterienzutrafen: 1. Pathologisches CTG. 2. Apgar-Score unter4 eine Minute p.p. und unter 6 fünf Minuten p.p. 3.Notwendigkeit einer Beatmung mit positiven Druckenüber mehr als eine Minute. 4. Metabolische Azidosemit einem pH < 7,2 in den ersten 20 Minuten. Zwanziggesunde Neugeborene dienten als Kontrollgruppe. Amersten und dritten Lebenstag wurde die Nierenfunktiondurch konventionelle Methoden wie Creatininbestim-mung (Cr), endogene Creatinin-Clearance (Ccr) undfraktionierte Natrium-Ausscheidung (FeNa) sowieauch durch radioimmunologische Messung des ß2-Mi-kroglobulins im Urin (Feß2-m) und Serum bestimmt.Bei der Analyse der Daten erfolgte auch eine Zuord-nung zu einer aufgetretenen Oligurie (Harnfluß gerin-ger als 0,8 ml/kg/h) bzw. zu einem akuten Nieren ver-sagen (Harnfluß geringer als 1,0 ml/kg/h, bei Volu-menauffüllung keine Reaktion, Creatinin im Serumhöher als 1,5 mg/dl).Elf asphyktische Neugeborene entwickelten eine Olig-urie und fünf ein akutes Nierenversagen. Beide Kom-plikationen traten in der Kontrollgruppe nicht auf.Sowohl die konventionellen Tests wie auch das ß2-mim Urin, nicht aber das ß2-m im Serum lieferten signi-

fikant unterschiedliche Werte (p < 0,01) zwischen As-phyxie- und Kontrollgruppe (Tab. I). Bei Klassifizie-rung (Tab. II) zeigte sich, daß hinsichtlich der Oligurienur das Serumcreatinin, die ß2-m/Cr-Ratio und dasFeß_-m in der Lage waren, am ersten Lebenstag zwi-schen einer Oligurie und einer verzögerten Diurese zuunterscheiden. Bezogen auf ein akutes Nierenversagenwaren am ersten Lebenstag lediglich Ccr und Feß2-munterschiedlich. Am dritten Lebenstag fanden sich inallen Gruppen mit Ausnahme des Creatinin, nach des-sen Höhe ein akutes Nierenversagen definiert wurde,keine Unterschiede. Die Sensitivität der ß2-m/Cr-Ratioim Urin, des Feß2-m und der FeNa betrug 0,70, 0,75und 0,65, die Spezifität lag bald bei 0,95, 0,95 und0,85.Im Gegensatz zu Erwachsenen kann bei Neugeborenendas Serum-ß2-m nicht als Parameter der glomerulärenFiltrationsrate angesehen werden. Der Schaden improximalen Tubulus nach Asphyxiw führt zu einerverminderten Reabsorption von ß2-m und daraus fol-gend zu einer erhöhten ß2-m/Cr-Ratio im Urin wieauch eines vermehrten Feß2-m bei Oligurie. Nach derFeNa ist weder eine Zuordnung zu der Gruppe mitOligurie noch zur Gruppe mit eingeschränkter Nieren-funktion möglich. Wir glauben daher, daß die ß2-m/Cr-Ratio im Urin und die Feß2-m sensitive und spe-zifische Tests zur frühen Erkennung einer Störung desproximalen Tubulus nach perinataler Asphyxie dar-stellen.

Schlüsselwörter: ß2-Mikroglobulin, Nierenfunktiontests, perinatale Asphyxie, Sensitivität, Spezifizität.

Resume

La ß2 microglobuline dans Pappreciation de la functionrenale des nouveaux-nes a terme apres asphyxie peri-nataleOn a etudie vingt nouveaux-nes ä terme ayant subiune asphyxie avec au moins trois des criteres suivants:1. surveillance du rythme cardiaque anormale, 2. scored'Apgar inferieur ä 4 a une minute, et inferieur a 6 ä5 minutes de vie, 3. necessite d'une ventilation ä pres-sion positive superieure ä une minute, 4. acidose me-tabolique avec pH < 7,2 au cours des 20 minutes apresla naissance, ainsi que vingt nouveaux-nes ä terme bienportants afin d'evaluer Putilite clinique du dosage se-

rique et urinaire de la ß2 microglobuline (ß2-m) commemarqueur de lesions renales secondaires a une asphyxieperinatale. On a surveille la fonction renale au premieret au troisieme jour apres la naissance au moyen destests traditionnels tels que la creatinine (Cr), la clea-rance de la creatinine endogene (Ccr) et Fexcretionfractionnelle du sodium (FeNa), ainsi que au moyendu dosage radio-immunologique serique et urinaire dela ß2 microglobuline. On a analyse les donnees pour legroupe dans son ensemble et apres realisation de sousgroupes en fonction de la presence d'une oligurie de-finie par un debit urinaire inferieur ä 0,8 ml/Kg/heure

J. Perinat. Med. 17 (1989)

458 Fernandez et al, ß2 microglobulin and renal function after perinatal asphyxia

et d'une insuffisance renale aigüe (IRA) definie par undebit urinaire inferieur ä 1,0 ml/Kg/heure, ne repon-dant pas ä un remplissage avec une creatinine seriquesuperieure a 1,5 mg/dl.Onze nouveaux-nes asphyxies ont presente une oligurieet cinq une IRA, contre aucun des temoins. Tous lestests traditionnels de la fonction renale ainsi que lesdosages de la ß2-m, ä l'exception de la ß2-m serique,etaient signiflcativement differents (p < 0,01) entre lesnouveaux-nes temoins et asphyxies (tableau I). AvecFanalyse des sous-groupes (tableau II) seuls la Cr se-rique, le ratio ß2-m urinaire/Cr et Feß2m permettentde discriminer l'oligurie de la diurese conservee aucours du premier jour de vie. En ce qui concerne 1'IRA,seuls la Ccr et la Feß2-m etaient differents, egalementau cours du premier jour de vie. On n'a pas observede differences au troisieme jour quel que soit le groupe,ä l'exception de la Cr qui est utilisee pour definir 1'IRA.

Les sensibilites du ratio ß2-m urinaire/creatinine, de laFeß2-m et de la FeNa sont de 0,70, 0,75 et de 0,65 etles specificites respectivement de 0,95, 0,95 et de 0,85.En contraste avec la situation des adultes, la ß2-mserique ne peut etre utilisee chez les nouveaux-nescomme index du taux de filtration glomerulaire. Leslesions tubulaires proximales renales secondaires ä uneasphyxie perinatale semblent rendre compte de la ca-pacite reduite de reabsorption de la ß2-m et par la, dePaugmentation du ratio ß2-m urinaire/Cr et de la Feß2-m trouvee en presence d'une oligurie. Le FeNA n'estpas utile pour placer le nouveau-ne ni dans le groupeoligurique ni dans le groupe avec fonction renale re-duite. Ainsi, le ratio ß2-m urinaire/creatinine et la Feß2-m apparaissent etre des tests sensibles et specifiquespour le depistage precoce de la dysfonction tubulaireproximale renale secondaire ä Pasphyxie perinatale.

Mots-cles: Asphyxie perinatale, ß2 microglobuline, sensibilite, specificite, tests de la fonction renale.

Acknowledgement: This study was supported by a grant from Heinz Koch Foundation, 1988.

References

[1] ANAND SK: Acute renal failure in the neonate.Fed Clin North Am 29 (1982) 791

[2] ASSADI FK, E CHOW-TUNG: Renal handling ofbeta-2-microglobulin in neonates treated withgentamicin. Nephron 49 (1988) 114

[3] ASSADI FK, EG JOHN, P JUSTICE, L FORNELL: ß2microglobulin clearance in neonates: index of tu-bular maturation. Kidney Int 28 (1985) 153

[4] BERHMAN RE, MH LEES, EN PETERSON, CW DELANNOY, AE SEEDS: Distribution of the circulationin the normal and asphyxiated fetal primate. AmJ Obstet Gynecol 108 (1970) 956

[5] CEJKA J, C FLOSSIE, K, KITHIER: Serum ß2-micro-globulin levels in normal children and sex-linkedagammaglobulinemia patients. Clin Chim Acta 47(1973) 59

[6] COHN HE, EJ SACKS, MA HEYMANN, AM RU-DOLPH: Cardiovascular responses to hypoxemiaand ischemia in fetal lambs. Am J Obstet Gynecol120 (1974) 817

[7] COLE JW, RJ PORTMAN, LIN, JM PERLMAN, AMROBSON: Urinary ß2-microglobulin in full termsnewborns: evidence for proximal tubular dysfunc-tion in infants with meconium stained amnioticfluid. Pediatrics 76 (1985) 958

[8] DAUBER IM, AN KRAUSS, PS SYMCHYCH, PAMAULD: Renal failure following perinatal anoxia. JPediatr 88 (1976) 851

[9] ELLIS EN, WC ARNOLD: Use of urinary indexesin renal failure in the newborn. Am J Dis Child136 (1982) 615

[10] ENGLE WD, BS ARANT: Renal handling of beta-2-microglobulin in the human neonate. KidneyInt 24 (1983) 358

[11] GOUYON JB, AUJARD, A ABISROR, N LAUDIG-NON, P D'Anns, E JACQZ, D , JF DEMELIER,H MATHIEU: Urinary excretion of N-Acetyl-Glu-cosaminidase and beta-2-microglobulin as earlymarkers of gentamicin nephrotoxicity in neonates.Rev Pharmacol Ther 10 (1987) 145

[12] HALL PW, M CHUNG-PARK, CV VACCA, M LON-DON, AQ CROWLEY: The renal handling of beta2-microglobulin in the dog. Kidney Int 22 (1982)156

[13] HALL PW, ES RICANATI: Renal handling of ß2microglobulin in renal disorders: with special re-ference to hepatorenal syndrome. Nephron 27(1981) 62

[14] LEROY D, F MAURIAT, M DECHAUX, N CHOPIN,M BROYERS, C SACHS: La ß2 microblobuline: indexde la filtration glomerulaire chez 1'enfant. ArchFr Pediatr 41 (1984) 43

[15] MATHEW OP, AS JONAS, E JAMES, H BLAND, TGROSHONG: Neonatal renal failure: usefulness ofdiagnostic indices. Pediatrics 65 (1980) 57

[16] NORMAN ME, FK ASSADI: A prospective study ofacute renal failure in the newborn infant. Pedi-atrics 63 (1979) 475

[17] SAS User's Guide. 5th Ed. Gary, North Carolina:SAS institute, Inc. 1985

[18] SCHARDIJN GHC, LW STATIUS VAN EPS: ß2 mi-croglobulin: its significance in the evaluation ofrenal function. Kidney Int 32 (1987) 635

J. Perinat. Med. 17 (1989)

Fernandez et al, ß2 microglobulin and renal function after perinatal asphyxia 459

[19] STAPELTON FB, DP JONES, RS GREEN: Acute renal [23] TAOEDDINE F, M TABBARA, P HALL, RJ SOKOL,failure in neonates: incidence, etiology, and out- KC KING: Fetal renal maturation. Studies oncome. Pediatr Nephrol 1 (1987) 314 urinary beta 2 microglobulin in the neonate. Acta

[20] STARK H, R GEIGER: Renal tubular dysfunction Obstet Gynecol Scand 62 (1983) 311following vascular accidents of the kidneys in thenewborn period. J Pediatr 83 (1973) 933 Received August 24, 1989. Accepted October 16,

[21] STATUTS VAN EPS LW, GHC SCHARDIJN: ß2 mi- 1939croglobulin and the renal tubule. In: LUBEC G(ed): Non-invasive diagnosis of kidney disease. Dr. Vicente BarrioKarger, Basel 1983, 103 Departamento de Nefrologia

[22] TACK ED, JM PERLMAN, AM ROBSON: Renal in- Hospital "Reina Sofia"jury in sick newborn infants: a prospective eval- Avda. Menendez Pidal s/nuation using urinary ß2-microglobulin concentra- 14004 Cordoba, Spaintions. Pediatrics 81 (1988) 432

J. Perinat. Med. 17 (1989)